Author:
Li Xiong,Liu Youhong,Tang Yong,Roger Phipps,Jeng Meei-Huey,Kao Chinghai
Subject
Genetics (clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine
Reference42 articles.
1. Systemic therapy after first-line docetaxel in metastatic castration-resistant prostate cancer;Beardsley;Curr Opin Support Palliat Care,2008
2. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004
3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004
4. A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2;Friedland;Semin Oncol,1999
5. Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: preliminary results;Picus;Semin Oncol,1999
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献